A comparison of prompting methods to teach sight words to students with autism spectrum disorder

Klaus, Sophie; Hixson, Michael D; Drevon, Daniel D.; Nutkins, Christie

doi:10.1002/bin.1667

Cited by 9 publications

(2 citation statements)

References 18 publications

(30 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Autism Spectrum Disorder (ASD) is caused by early neuron developmental dysfunction and lasts for the entirety of life, lacking clear etiology and genetic basis, but is linked to abnormal social communication and behaviors [ 75 , 76 ] [ 11 , 12 , 75 , 77 , 78 ]. The incidence of ASD is approximately 1 in 59 children and 1% of the global population according to the CDC statement ( https://www.afhu.org/2017/10/23/what-to-know-about-asd/?gclid=EAIaIQobChMI-oD087qQ7gIVh56zCh11og-UEAAYBCAAEgKxmPD_BwE ).…”

Section: Brain Organoid-based Modeling Of Neurological Disordersmentioning

confidence: 99%

Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening

Seong

et al. 2022

Stem Cells International

View full text Add to dashboard Cite

Clinical trials serve as the fundamental prerequisite for clinical therapy of human disease, which is primarily based on biomedical studies in animal models. Undoubtedly, animal models have made a significant contribution to gaining insight into the developmental and pathophysiological understanding of human diseases. However, none of the existing animal models could efficiently simulate the development of human organs and systems due to a lack of spatial information; the discrepancy in genetic, anatomic, and physiological basis between animals and humans limits detailed investigation. Therefore, the translational efficiency of the research outcomes in clinical applications was significantly weakened, especially for some complex, chronic, and intractable diseases. For example, the clinical trials for human fragile X syndrome (FXS) solely based on animal models have failed such as mGluR5 antagonists. To mimic the development of human organs more faithfully and efficiently translate in vitro biomedical studies to clinical trials, extensive attention to organoids derived from stem cells contributes to a deeper understanding of this research. The organoids are a miniaturized version of an organ generated in vitro, partially recapitulating key features of human organ development. As such, the organoids open a novel avenue for in vitro models of human disease, advantageous over the existing animal models. The invention of organoids has brought an innovative breakthrough in regeneration medicine. The organoid-derived human tissues or organs could potentially function as invaluable platforms for biomedical studies, pathological investigation of human diseases, and drug screening. Importantly, the study of regeneration medicine and the development of therapeutic strategies for human diseases could be conducted in a dish, facilitating in vitro analysis and experimentation. Thus far, the pilot breakthrough has been made in the generation of numerous types of organoids representing different human organs. Most of these human organoids have been employed for in vitro biomedical study and drug screening. However, the efficiency and quality of the organoids in recapitulating the development of human organs have been hindered by engineering and conceptual challenges. The efficiency and quality of the organoids are essential for downstream applications. In this article, we highlight the application in the modeling of human neurodegenerative diseases (NDDs) such as FXS, Alzheimer’s disease (AD), Parkinson’s disease (PD), and autistic spectrum disorders (ASD), and organoid-based drug screening. Additionally, challenges and weaknesses especially for limits of the brain organoid models in modeling late onset NDDs such as AD and PD., and future perspectives regarding human brain organoids are addressed.

show abstract

Section: Brain Organoid-based Modeling Of Neurological Disordersmentioning

confidence: 99%

Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening

Seong

et al. 2022

Stem Cells International

View full text Add to dashboard Cite

show abstract

“…In addition to the studies mentioned earlier, researchers have used SP to teach participants to expressively label (e.g., Johnson et al, 1996), receptively label (e.g., Tekin & Kircaali-Iftar, 2002), read (e.g., Schuster et al, 1992), and engage in self-help skills (e.g., Parrott et al, 2000). Furthermore, SP has been compared with constant time delay (e.g., Britton et al, 2017), direct instruction (e.g., Çelik & Kasapoglu, 2014), combined with and without error correction (e.g., Johnson et al, 1996), and progressive time delay (e.g., Klaus et al, 2019).…”

mentioning

confidence: 99%

Comparison of Simultaneous Prompting to Error Correction for Children With Autism Spectrum Disorder

Aljohani

Javed

Ferguson

et al. 2021

Focus Autism Other Dev Disabl

View full text Add to dashboard Cite

This study compared simultaneous prompting with an error correction procedure for teaching three children diagnosed with autism spectrum disorder expressive labels. Using a parallel treatment design nested into a multiple probe design, each participant was taught how to expressively label pictures of sports teams or cartoon characters using either simultaneous prompting or an error correction procedure. The goal was to evaluate the effectiveness, efficiency, and acquisition during teaching for each participant across the two conditions. Results indicated that both teaching procedures were effective, with high rates of maintenance, and all participants responded correctly during the majority of teaching trials.

show abstract

A Systematic Review of Simultaneous Prompting and Prompt Delay Procedures

Brown

Cariveau

2022

J Behav Educ

View full text Add to dashboard Cite

A comparison of prompting methods to teach sight words to students with autism spectrum disorder

Cited by 9 publications

References 18 publications

Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening

Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening

Comparison of Simultaneous Prompting to Error Correction for Children With Autism Spectrum Disorder

A Systematic Review of Simultaneous Prompting and Prompt Delay Procedures

Contact Info

Product

Resources

About